影像学技术在皮肌炎内脏受累诊断及预后评估中的应用进展

摘要/Abstract

中图分类号:

R593.26

张诗敏, 吴海曦, 杜联军, 胡赟赟, 曹华. 影像学技术在皮肌炎内脏受累诊断及预后评估中的应用进展[J]. 诊断学理论与实践, 2021, 20(01): 98-103.

参考文献46

[1]	Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis[J]. Clin Rheumatol, 2009, 28(8):979-984. doi:10.1007/s10067-009-1152-9 URL
[2]	Sun KY, Fan Y, Wang YX, et al. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020[J]. Semin Arthritis Rheum, 2021, 51(1):175-191. doi:10.1016/j.semarthrit.2020.11.009 URL
[3]	Long K, Danoff SK. Interstitial lung disease in polymyositis and dermatomyositis[J]. Clin Chest Med, 2019, 40(3):561-572. doi:10.1016/j.ccm.2019.05.004 URL
[4]	Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment[J]. J Am Acad Dermatol, 2020, 82(2):283-296. doi:S0190-9622(19)32308-4pmid:31279813
[5]	Cassius C, Le Buanec H, Bouaziz JD, et al. Biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome[J]. J Immunol Res, 2019, 2019:9141420.
[6]	Ye S, Chen XX, Lu XY, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study[J]. Clin Rheumatol, 2007, 26(10):1647-1654. doi:10.1007/s10067-007-0562-9 URL
[7]	Mira-Avendano I, Abril A, Burger CD, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases[J]. Mayo Clin Proc, 2019, 94(2):309-325. doi:S0025-6196(18)30704-3pmid:30558827
[8]	Zuo Y, Ye L, Liu M, et al. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis[J]. Rheumatology (Oxford), 2020, 59(10):2829-2837. doi:10.1093/rheumatology/keaa034pmid:32065646
[9]	Chino H, Sekine A, Baba T, et al. Interstitial lung disea-se with anti-melanoma differentiation-associated protein 5 antibody: rapidly progressive perilobular opacity[J]. Intern Med, 2019, 58(18):2605-2613. doi:10.2169/internalmedicine.2328-18 URL
[10]	Yamaguchi K, Yamaguchi A, Itai M, et al. Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum[J]. Clin Rheumatol, 2019, 38(12):3443-3450. doi:10.1007/s10067-019-04729-5pmid:31420814
[11]	Ichikado K, Suga M, Müller NL, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors[J]. Am J Respir Crit Care Med, 2002, 165(11):1551-1556. doi:10.1164/rccm.2106157 URL
[12]	Lian X, Zou J, Guo Q, et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model[J]. Chest, 2020, 158(4):1535-1545. doi:10.1016/j.chest.2020.04.057 URL
[13]	Xie HQ, Zhang WW, Sun S, et al. A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis[J]. Arthritis Res Ther, 2019, 21(1):93. doi:10.1186/s13075-019-1888-9 URL
[14]	Wang Y, Gargani L, Barskova T, et al. Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review[J]. Arthritis Res Ther, 2017, 19(1):206. doi:10.1186/s13075-017-1409-7 URL
[15]	Wang Y, Chen S, Lin J, et al. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease[J]. Rheumatology (Oxford), 2020, 59(8):2024-2029. doi:10.1093/rheumatology/kez571 URL
[16]	Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma disea-ses[J]. J Magn Reson Imaging, 2016, 43(2):512-532. doi:10.1002/jmri.25008 URL
[17]	Pinal-Fernandez I, Pineda-Sanchez V, Pallisa-Nuñez E, et al. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis[J]. Clin Rheumatol, 2016, 35(9):2339-2345. doi:10.1007/s10067-016-3267-0pmid:27107755
[18]	Lonzetti L, Zanon M, Pacini GS, et al. Magnetic resonance imaging of interstitial lung diseases: a state-of-the-art review[J]. Respir Med, 2019, 155:79-85. doi:S0954-6111(19)30229-Xpmid:31323528
[19]	Yi CA, Lee KS, Han J, et al. 3-T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation[J]. AJR Am J Roentgenol, 2008, 190(4):878-885. doi:10.2214/AJR.07.2833 URL
[20]	Montesi SB, Caravan P. Novel imaging approaches in systemic sclerosis-associated interstitial lung disease[J]. Curr Rheumatol Rep, 2019, 21(6):25. doi:10.1007/s11926-019-0826-9pmid:31025121
[21]	Lilleker JB, Roberts M, Diederichsen L. Cardiac involvement in inflammatory myopathies and inherited muscle diseases[J]. Curr Opin Rheumatol, 2020, 32(6):528-533. doi:10.1097/BOR.0000000000000753 URL
[22]	Opinc AH, Makowski MA, łukasik ZM, et al. Cardiovascular complications in patients with idiopathic inflammatory myopathies: does heart matter in idiopathic inflammatory myopathies?[J]. Heart Fail Rev, 2021, 26(1):111-125. doi:10.1007/s10741-019-09909-8 URL
[23]	Jayakumar D, Zhang R, Wasserman A, et al. Cardiac manifestations in idiopathic inflammatory myopathies: an overview[J]. Cardiol Rev, 2019, 27(3):131-137. doi:10.1097/CRD.0000000000000241pmid:30585794
[24]	Liu Y, Fang L, Chen W, et al. Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies[J]. Cardiovasc Diagn Ther, 2020, 10(3):405-420. doi:10.21037/cdt.2020.03.04 URL
[25]	Péter A, Balogh á, Szilágyi S, et al. Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis[J]. J Rheumatol, 2015, 42(2):272-281. doi:10.3899/jrheum.140626 URL
[26]	Zhong Y, Bai W, Xie Q, et al. Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study[J]. Int J Cardiovasc Imaging, 2018, 34(5):683-693. doi:10.1007/s10554-017-1278-9pmid:29168054
[27]	Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper[J]. J Am Coll Cardiol, 2009, 53(17):1475-1487. doi:10.1016/j.jacc.2009.02.007pmid:19389557
[28]	Rosenbohm A, Buckert D, Gerischer N, et al. Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography[J]. J Neurol, 2015, 262(4):949-956. doi:10.1007/s00415-014-7623-1pmid:25673126
[29]	Yu L, Sun J, Sun J, et al. Early detection of myocardial involvement by T(1) mapping of cardiac MRI in idiopat-hic inflammatory myopathy[J]. J Magn Reson Imaging, 2018, 48(2):415-422. doi:10.1002/jmri.25945 URL
[30]	Xu Y, Sun J, Wan K, et al. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy[J]. J Cardiovasc Magn Reson, 2020, 22(1):22. doi:10.1186/s12968-020-00616-0 URL
[31]	Weng MY, Lai EC, Kao Yang YH. Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan[J]. Rheumatology (Oxford), 2019, 58(11):1935-1941. doi:10.1093/rheumatology/kez076 URL
[32]	Escárcega RO, Lipinski MJ, García-Carrasco M, et al. Inflammation and atherosclerosis: cardiovascular evaluation in patients with autoimmune diseases[J]. Autoimmun Rev, 2018, 17(7):703-708. doi:S1568-9972(18)30110-1pmid:29730525
[33]	Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology[J]. Circulation, 2006, 114(16):1761-1791. doi:10.1161/CIRCULATIONAHA.106.178458 URL
[34]	Carruthers EC, Choi HK, Sayre EC, et al. Risk of deep venous thrombosis and pulmonary embolism in indivi-duals with polymyositis and dermatomyositis: a general population-based study[J]. Ann Rheum Dis, 2016, 75(1):110-116. doi:10.1136/annrheumdis-2014-205800pmid:25193998
[35]	Fang YF, Wu YJ, Kuo CF, et al. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients[J]. Clin Rheumatol, 2016, 35(8):1977-1984. doi:10.1007/s10067-016-3296-8 URL
[36]	Selva-O'Callaghan A, Martinez-Gómez X, Trallero-Araguás E, et al. The diagnostic work-up of cancer-associated myositis[J]. Curr Opin Rheumatol, 2018, 30(6):630-636. doi:10.1097/BOR.0000000000000535pmid:29965856
[37]	Hoesly PM, Sluzevich JC, Jambusaria-Pahlajani A, et al. Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis[J]. J Am Acad Dermatol, 2019, 80(5):1364-1370. doi:S0190-9622(18)32913-Xpmid:30458207
[38]	Galimberti F, Li Y, Husni EM, et al. Dermatomyositis and malignancy: a proposal for evidence-based malignancy screening guidelines[J]. J Am Acad Dermatol, 2016, 74(5):AB170.
[39]	Leatham H, Schadt C, Chisolm S, et al. Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts[J]. Medicine (Baltimore), 2018, 97(2):e9639. doi:10.1097/MD.0000000000009639 URL
[40]	Huang ZG, Gao BX, Chen H, et al. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis[J]. PLoS One, 2017, 12(7):e0181069. doi:10.1371/journal.pone.0181069 URL
[41]	Selva-O'Callaghan A, Grau JM, Gámez-Cenzano C, et al. Conventional cancer screeningversusPET/CT in dermatomyositis/polymyositis[J]. Am J Med, 2010, 123(6):558-562. doi:10.1016/j.amjmed.2009.11.012pmid:20569766
[42]	Maliha PG, Hudson M, Abikhzer G, et al.¹⁸F-FDG PET/CTversusconventional investigations for cancer scree-ning in autoimmune inflammatory myopathy in the era of novel myopathy classifications[J]. Nucl Med Commun, 2019, 40(4):377-382. doi:10.1097/MNM.0000000000000981pmid:30664602
[43]	Matuszak J, Blondet C, Hubelé F, et al. Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity[J]. Rheumatology (Oxford), 2019:kez040.
[44]	Li Y, Zhou Y, Wang Q. Multiple values of¹⁸F-FDG PET/CT in idiopathic inflammatory myopathy[J]. Clin Rheumatol, 2017, 36(10):2297-2305. doi:10.1007/s10067-017-3794-3 URL
[45]	Nakamura N, Izumi R, Hoshi Y, et al. FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis[J]. Rheumatology (Oxford), 2019, 58(10):1888. doi:10.1093/rheumatology/kez083pmid:30879053
[46]	Selva-O'Callaghan A, Gil-Vila A, Simó-Perdigó M, et al. PET scan: nuclear medicine imaging in myositis[J]. Curr Rheumatol Rep, 2019, 21(11):64. doi:10.1007/s11926-019-0864-3pmid:31754890

影像学技术在皮肌炎内脏受累诊断及预后评估中的应用进展

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献46

相关文章15

编辑推荐

Metrics

本文评价

[1]	车稳, 柳蒋书, 陈晓炎, 王朝夫, 袁菲, 王璇.肺混合性鳞状细胞和腺性乳头状瘤2例临床病理特征及冷冻切片病理诊断误诊分析[J]. 诊断学理论与实践, 2022, 21(04): 476-481.
[2]	马雪菲, 王学锋, 王侃侃.浆细胞瘤变异体易位1和MYC基因在泛癌中的表达及生存期预测价值分析[J]. 诊断学理论与实践, 2022, 21(04): 490-496.
[3]	何新, 陈慧, 冯炜炜.机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[4]	张浩, 池慧慧, 苏禹同, 杨程德.特发性炎性肌病自身抗体与临床表型间关联的研究进展[J]. 诊断学理论与实践, 2022, 21(03): 408-414.
[5]	杨伯文, 姜美娇, 陈慧.超声IOTA简单法鉴别诊断卵巢肿瘤良恶性的临床研究[J]. 诊断学理论与实践, 2022, 21(01): 74-79.
[6]	姚伟武, 张欢.线上教学对医学影像的影响及现状思考[J]. 诊断学理论与实践, 2022, 21(01): 99-101.
[7]	陈勇, 张欢.线上自适应教程在医学影像学专业型硕士研究生教学实践中的应用[J]. 诊断学理论与实践, 2021, 20(06): 596-598.
[8]	张华, 陆炜, 杨承翌, 项明洁.血清人衰老关键蛋白1检测对结肠直肠癌的诊断和预后价值[J]. 诊断学理论与实践, 2021, 20(05): 462-465.
[9]	李娟, 刘劲松, 李梅, 李殿炜, 朱弘.细支气管腺瘤10例临床病理分析及文献复习[J]. 诊断学理论与实践, 2021, 20(05): 466-470.
[10]	苏长青.从基础研究到临床转化应用谈肝癌的诊治进展[J]. 诊断学理论与实践, 2021, 20(05): 427-433.
[11]	钱乐, 姜美娇, 杨伯文, 陈慧.卵巢囊性腺纤维瘤和卵巢腺纤维瘤的超声诊断效能及图像特征分析[J]. 诊断学理论与实践, 2021, 20(02): 161-167.
[12]	安晓宁, 魏兆楠, 沈艳, 史浩, 张文, 陈永熙.耗竭巨噬细胞抑制脂多糖诱导小鼠肾脏及全身炎症损伤的作用研究[J]. 诊断学理论与实践, 2021, 20(02): 195-200.
[13]	赖丽梅, 周建桥.超声引导下射频消融术在甲状腺结节治疗中的应用进展[J]. 诊断学理论与实践, 2021, 20(02): 216-220.
[14]	曹华, 郑捷.抗MDA5抗体阳性皮肌炎患者的临床特征、诊断与预后[J]. 诊断学理论与实践, 2021, 20(01): 8-14.
[15]	刘畅, 曹华, 冯炜炜, 沈立翡.皮肌炎合并妇科恶性肿瘤11例临床特征与短期随访结局分析[J]. 诊断学理论与实践, 2021, 20(01): 53-59.